AAAAAA
Results: 1-25/57
Authors:
MARTIN P
CARLSSON ML
HJORTH S
Citation: P. Martin et al., SYSTEMIC PCP TREATMENT ELEVATES BRAIN EXTRACELLULAR 5-HT - A MICRODIALYSIS STUDY IN AWAKE RATS, NeuroReport, 9(13), 1998, pp. 2985-2988
Authors:
BENGTSSON HJ
PEILOT H
HJORTH S
Citation: Hj. Bengtsson et al., THE TRY WAY APPROACH - COMBINED TREATMENT WITH L-TRYPTOPHAN AND THE 5-HT1A (AUTO)RECEPTOR ANTAGONIST WAY100635 INCREASES 5-HT OUTPUT IN THERAT FRONTAL-CORTEX BUT NOT IN THE DORSAL HIPPOCAMPUS/, Nordic journal of psychiatry, 52(2), 1998, pp. 105-106
Authors:
WIKELL C
BERGQVIST PBF
APELQVIST G
HJORTH S
BENGTSSON F
Citation: C. Wikell et al., VENLAFAXINE CHALLENGE ALTERS THE BRAIN MONOAMINE OUTPUT IN EXPERIMENTAL HEPATIC-ENCEPHALOPATHY, Nordic journal of psychiatry, 52(2), 1998, pp. 124-125
Authors:
WIKELL C
BERGQVIST PBF
APELQVIST G
HJORTH S
BENGTSSON F
Citation: C. Wikell et al., VENLAFAXINE CHALLENGE ALTERS THE BRAIN MONOAMINE OUTPUT IN EXPERIMENTAL HEPATIC-ENCEPHALOPATHY, Nordic journal of psychiatry, 52(2), 1998, pp. 124-124
Authors:
HJORTH S
KULLBERG A
MILLAN MJ
BENGTSSON HJ
Citation: S. Hjorth et al., ALPHA(1)-ADRENOCEPTOR 5-HYDROXYTRYPTAMINE (5-HT1A) AUTORECEPTOR MEDIATION OF THE 5-HT RELEASE-REDUCING ACTION OF CLOZAPINE AND S16924 IN RAT VENTRAL HIPPOCAMPUS/, Nordic journal of psychiatry, 52(2), 1998, pp. 126-127
Authors:
PEILOT H
BENGTSSON HJ
HJORTH S
Citation: H. Peilot et al., REGIONAL DIFFERENCES IN AUTORECEPTOR CONTROL OF 5-HYDROXYTRYPTAMINE RELEASE IN THE RAT CENTRAL-NERVOUS-SYSTEM IN-VIVO, Nordic journal of psychiatry, 52(2), 1998, pp. 128-128
Authors:
WIKELL C
BERGQVIST PBF
HJORTH S
APELQVIST G
BJORK H
BENGTSSON F
Citation: C. Wikell et al., BRAIN MONOAMINE OUTPUT ALTERATIONS AFTER A SINGLE VENLAFAXINE CHALLENGE IN EXPERIMENTAL HEPATIC-ENCEPHALOPATHY, Clinical neuropharmacology, 21(5), 1998, pp. 296-306
Authors:
BENGTSSON HJ
KULLBERG A
MILLAN MJ
HJORTH S
Citation: Hj. Bengtsson et al., THE ROLE OF 5-HT1A AUTORECEPTORS AND ALPHA(1)-ADRENOCEPTORS IN THE MODULATION OF 5-HT RELEASE - III - CLOZAPINE AND THE NOVEL PUTATIVE ANTIPSYCHOTIC S-16924, Neuropharmacology, 37(3), 1998, pp. 349-356
Authors:
BERGQVIST PBF
HJORTH S
APELQVIST G
BENGTSSON F
Citation: Pbf. Bergqvist et al., POTASSIUM-EVOKED NEURONAL RELEASE OF SEROTONIN IN EXPERIMENTAL CHRONIC PORTAL-SYSTEMIC ENCEPHALOPATHY, Metabolic brain disease, 12(3), 1997, pp. 193-202
Authors:
BERGQVIST PBF
HJORTH S
WIKELL C
APELQVIST G
BENGTSSON F
Citation: Pbf. Bergqvist et al., P-CHLOROAMPHETAMINE-INDUCED AND D-FENFLURAMINE-INDUCED BRAIN-SEROTONIN RELEASE IN EXPERIMENTAL PORTAL-SYSTEMIC ENCEPHALOPATHY, Metabolic brain disease, 12(3), 1997, pp. 229-236
NEURONAL RELEASE OF SEROTONIN IN EXPERIMENTAL CHRONIC HEPATIC-ENCEPHALOPATHY - EFFECTS OF CITALOPRAM
Authors:
WIKELL C
BERGQVIST PBF
HJORTH S
APELQVIST G
BENGTSSON F
Citation: C. Wikell et al., NEURONAL RELEASE OF SEROTONIN IN EXPERIMENTAL CHRONIC HEPATIC-ENCEPHALOPATHY - EFFECTS OF CITALOPRAM, Nordic journal of psychiatry, 51(2), 1997, pp. 90-90
Authors:
HJORTH S
WESTLIN D
BENGTSSON HJ
Citation: S. Hjorth et al., RELATIVE IMPORTANCE OF 5-HYDROXYTRYPTAMINE (5-HT) REUPTAKE INHIBITIONAND 5-HT1A AUTORECEPTOR BLOCKADE IN THE CITALOPRAM PLUS WAY100635-INDUCED INCREASE OF EXTRACELLULAR 5-HT IN THE RAT-BRAIN IN-VIVO, Nordic journal of psychiatry, 51(2), 1997, pp. 100-100
Authors:
BENGTSSON HJ
HJORTH S
Citation: Hj. Bengtsson et S. Hjorth, REGIONAL DIFFERENCES IN THE EFFECT OF THE 5-HYDROXYTRYPTAMINE-1A AUTORECEPTOR ANTAGONIST WAY100635 ON THE 5-HT-INCREASING RESPONSE TO THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR CITALOPRAM IN-VIVO, Nordic journal of psychiatry, 51(2), 1997, pp. 101-101
Authors:
BERGQVIST PBF
WIKELL C
HJORTH S
APELQVIST G
BENGTSSON F
Citation: Pbf. Bergqvist et al., EFFECT OF CITALOPRAM ON BRAIN-SEROTONIN RELEASE IN EXPERIMENTAL HEPATIC-ENCEPHALOPATHY - IMPLICATIONS FOR THYMOLEPTIC DRUG SAFETY IN LIVER INSUFFICIENCY, Clinical neuropharmacology, 20(6), 1997, pp. 511-522
Authors:
HJORTH S
WESTLIN D
BENGTSSON HJ
Citation: S. Hjorth et al., WAY100635-INDUCED AUGMENTATION OF THE 5-HT-ELEVATING ACTION OF CITALOPRAM - RELATIVE IMPORTANCE OF THE DOSE OF THE 5-HT1A (AUTO)RECEPTOR BLOCKER VERSUS THAT OF THE 5-HT REUPTAKE INHIBITOR, Neuropharmacology, 36(4-5), 1997, pp. 461-465
Authors:
GUNDLAH C
HJORTH S
AUERBACH SB
Citation: C. Gundlah et al., AUTORECEPTOR ANTAGONISTS ENHANCE THE EFFECT OF THE REUPTAKE INHIBITORCITALOPRAM ON EXTRACELLULAR 5-HT - THIS EFFECT PERSISTS AFTER REPEATED CITALOPRAM TREATMENT, Neuropharmacology, 36(4-5), 1997, pp. 475-482
Authors:
MILLAN MJ
HJORTH S
SAMANIN R
SCHREIBER R
JAFFARD R
DELADONCHAMPS B
VEIGA S
GOUMENT B
PEGLION JL
SPEDDING M
BROCCO M
Citation: Mj. Millan et al., S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .2. MODULATION OF HIPPOCAMPAL SEROTONIN RELEASE IN RELATION TO POTENTIAL ANXIOLYTIC PROPERTIES, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 148-161
Authors:
BERGQVIST PBF
WIKELL C
HJORTH S
APELQVIST G
BENGTSSON F
Citation: Pbf. Bergqvist et al., NEOCORTICAL RELEASE OF SEROTONIN IN EXPERIMENTAL CHRONIC HEPATIC-ENCEPHALOPATHY - EFFECTS OF CITALOPRAM, Journal of neurochemistry, 69, 1997, pp. 62-62
Authors:
BERGQVIST PBF
WIKELL C
HJORTH S
APELQVIST G
BENGTSSON F
Citation: Pbf. Bergqvist et al., NEOCORTICAL RELEASE OF SEROTONIN IN EXPERIMENTAL CHRONIC PORTAL-SYSTEMIC ENCEPHALOPATHY - EFFECTS OF CITALOPRAM, Gastroenterology, 112(4), 1997, pp. 1226-1226
Authors:
CARRIERE F
THIRSTRUP K
HJORTH S
FERRATO F
NIELSEN PF
WITHERSMARTINEZ C
CAMBILLAU C
BOEL E
THIM L
VERGER R
Citation: F. Carriere et al., PANCREATIC LIPASE STRUCTURE-FUNCTION-RELATIONSHIPS BY DOMAIN EXCHANGE, Biochemistry, 36(1), 1997, pp. 239-248
Authors:
BERGQVIST PBF
HJORTH S
AUDET RM
APELQVIST G
BENGTSSON F
BUTTERWORTH RF
Citation: Pbf. Bergqvist et al., AMMONIUM ACETATE CHALLENGE IN EXPERIMENTAL CHRONIC HEPATIC-ENCEPHALOPATHY INDUCES A TRANSIENT INCREASE OF BRAIN 5-HT RELEASE IN-VIVO, European neuropsychopharmacology, 6(4), 1996, pp. 317-322
Authors:
BERGQVIST PBF
HJORTH S
APELQVIST G
BENGTSSON F
Citation: Pbf. Bergqvist et al., ACUTE EFFECTS OF L-TRYPTOPHAN ON BRAIN EXTRACELLULAR 5-HT AND 5-HIAA LEVELS IN CHRONIC EXPERIMENTAL PORTAL-SYSTEMIC ENCEPHALOPATHY, Metabolic brain disease, 11(3), 1996, pp. 269-278
Authors:
HJORTH S
BENGTSSON HJ
MILANO S
Citation: S. Hjorth et al., THE 5-HYDROXYTRYPTAMINE (5-HT)1A ANTAGONISTS WAY-100635 AND (-)PINDOLOL AUGMENT THE 9-HT-INCREASING EFFECT OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR CITALOPRAM IN-VIVO, WHEREAS BUSPIRONE DOES NOT - SYSTEMIC AND INTRA-RAPHE DRUG INJECTION STUDIES, Nordic journal of psychiatry, 50(2), 1996, pp. 96-96
Authors:
SHARP T
UMBERS V
HJORTH S
Citation: T. Sharp et al., THE ROLE OF 5-HT1A AUTORECEPTORS AND ALPHA(1)-ADRENOCEPTORS IN THE INHIBITION OF 5-HT RELEASE .2. NAN-190 AND SDZ-216-525, Neuropharmacology, 35(6), 1996, pp. 735-741
Authors:
BERGQVIST PBF
HJORTH S
AUDET RM
APELQVIST G
BUTTERWORTH RF
BENGTSSON F
Citation: Pbf. Bergqvist et al., EFFECTS OF AMMONIA AND 1-TRYPTOPHAN LOADING ON BRAIN EXTRACELLULAR 5-HT AND 5-HIAA LEVELS IN EXPERIMENTAL HEPATIC-ENCEPHALOPATHY, Journal of neurochemistry, 66, 1996, pp. 49-49